These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 32959249)
21. Reduction of free polysaccharide contamination in the production of a 15-valent pneumococcal conjugate vaccine. Whang YH; Kim SK; Yoon H; Choi SK; Baik YO; Lee C; Lee I PLoS One; 2020; 15(12):e0243909. PubMed ID: 33301525 [TBL] [Abstract][Full Text] [Related]
22. Anti-Group B Streptococcus Glycan-Conjugate Vaccines Using Pilus Protein GBS80 As Carrier and Antigen: Comparing Lysine and Tyrosine-directed Conjugation. Nilo A; Morelli L; Passalacqua I; Brogioni B; Allan M; Carboni F; Pezzicoli A; Zerbini F; Maione D; Fabbrini M; Romano MR; Hu QY; Margarit I; Berti F; Adamo R ACS Chem Biol; 2015 Jul; 10(7):1737-46. PubMed ID: 25906283 [TBL] [Abstract][Full Text] [Related]
23. Protein Carriers for Glycoconjugate Vaccines: History, Selection Criteria, Characterization and New Trends. Micoli F; Adamo R; Costantino P Molecules; 2018 Jun; 23(6):. PubMed ID: 29914046 [TBL] [Abstract][Full Text] [Related]
29. Generalized Modules for Membrane Antigens as Carrier for Polysaccharides: Impact of Sugar Length, Density, and Attachment Site on the Immune Response Elicited in Animal Models. Micoli F; Alfini R; Di Benedetto R; Necchi F; Schiavo F; Mancini F; Carducci M; Oldrini D; Pitirollo O; Gasperini G; Balocchi C; Bechi N; Brunelli B; Piccioli D; Adamo R Front Immunol; 2021; 12():719315. PubMed ID: 34594333 [TBL] [Abstract][Full Text] [Related]
30. Overexpression of O-polysaccharide chain length regulators in Gram-negative bacteria using the Wzx-/Wzy-dependent pathway enhances production of defined modal length O-polysaccharide polymers for use as haptens in glycoconjugate vaccines. Hegerle N; Bose J; Ramachandran G; Galen JE; Levine MM; Simon R; Tennant SM J Appl Microbiol; 2018 Aug; 125(2):575-585. PubMed ID: 29603538 [TBL] [Abstract][Full Text] [Related]
31. Carrier priming with CRM 197 or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: biophysical and immunochemical interpretation. Pecetta S; Lo Surdo P; Tontini M; Proietti D; Zambonelli C; Bottomley MJ; Biagini M; Berti F; Costantino P; Romano MR; Vaccine; 2015 Jan; 33(2):314-20. PubMed ID: 25448110 [TBL] [Abstract][Full Text] [Related]
32. Direct Conjugation of Bacterial Polysaccharides to Proteins by Squaric Acid Chemistry. Xu P; Kováč P Methods Mol Biol; 2019; 1954():89-98. PubMed ID: 30864126 [TBL] [Abstract][Full Text] [Related]
33. The adjuvant effect of TLR7 agonist conjugated to a meningococcal serogroup C glycoconjugate vaccine. Donadei A; Balocchi C; Mancini F; Proietti D; Gallorini S; O'Hagan DT; D'Oro U; Berti F; Baudner BC; Adamo R Eur J Pharm Biopharm; 2016 Oct; 107():110-9. PubMed ID: 27388628 [TBL] [Abstract][Full Text] [Related]
34. Polysaccharide structure dictates mechanism of adaptive immune response to glycoconjugate vaccines. Sun X; Stefanetti G; Berti F; Kasper DL Proc Natl Acad Sci U S A; 2019 Jan; 116(1):193-198. PubMed ID: 30510007 [TBL] [Abstract][Full Text] [Related]
35. Conjugate Vaccines from Bacterial Antigens by Squaric Acid Chemistry: A Closer Look. Xu P; Kelly M; Vann WF; Qadri F; Ryan ET; Kováč P Chembiochem; 2017 Apr; 18(8):799-815. PubMed ID: 28182850 [TBL] [Abstract][Full Text] [Related]
36. Towards a synthetic glycoconjugate vaccine against Neisseria meningitidis A. Berkin A; Coxon B; Pozsgay V Chemistry; 2002 Oct; 8(19):4424-33. PubMed ID: 12355530 [TBL] [Abstract][Full Text] [Related]
37. Immunogenicity and protective efficacy against Schuster O; Sears KT; Ramachandran G; Fuche FJ; Curtis B; Tennant SM; Simon R Hum Vaccin Immunother; 2019; 15(6):1436-1444. PubMed ID: 29873578 [TBL] [Abstract][Full Text] [Related]
38. [Carbohydrates and vaccines: from purified polysaccharides to semi-synthetic glycoconjugate vaccines]. Mulard L Ann Pharm Fr; 2007 Jan; 65(1):14-32. PubMed ID: 17299349 [TBL] [Abstract][Full Text] [Related]